Management of Barrett’s esophageal carcinoma

[1]  Paul Fockens,et al.  Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial , 2012, Gut.

[2]  V. Gebski,et al.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.

[3]  H. Lang,et al.  Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients , 2011, Expert review of gastroenterology & hepatology.

[4]  J. Going,et al.  Still waiting for predictive biomarkers in Barrett's oesophagus , 2011, Journal of Clinical Pathology.

[5]  R. Langer,et al.  Long-term Outcome of 2920 Patients With Cancers of the Esophagus and Esophagogastric Junction: Evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee Staging System , 2011, Annals of surgery.

[6]  P. Willson,et al.  Esophageal adenocarcinoma after Nissen’s fundoplication for Barrett’s esophagus: report of a case , 2010, Surgery Today.

[7]  J. Emery,et al.  Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study , 2010, BMJ : British Medical Journal.

[8]  T. Gotoda,et al.  Prague C&M and Japanese criteria: shades of Barrett’s esophagus endoscopic diagnosis , 2010, Journal of Gastroenterology.

[9]  H. Welch,et al.  Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[10]  Hirokazu Takahashi,et al.  Gastric surgery is not a risk factor for erosive esophagitis or Barrett's esophagus , 2010, Scandinavian journal of gastroenterology.

[11]  C. Hawkey,et al.  Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis , 2010, Endoscopy.

[12]  E. Kuipers,et al.  Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study , 2009, The American Journal of Gastroenterology.

[13]  T. Hansen,et al.  Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2‐40 immunostaining , 2009, Journal of surgical oncology.

[14]  P. Went,et al.  Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  T. Ogihara,et al.  Utility of autofluorescence imaging videoendoscopy in screening for Barrett’s esophagus , 2009, Endoscopy.

[16]  H. Isomoto,et al.  ENDOSCOPIC SUBMUCOSAL DISSECTION OF A MINUTE INTRAMUCOSAL ADENOCARCINOMA IN BARRETT'S ESOPHAGUS , 2009, Digestive Endoscopy.

[17]  Carissa A. Sanchez,et al.  p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus , 2008, PloS one.

[18]  M. Rugge,et al.  Prediction of Lymph Node Status in Superficial Esophageal Carcinoma , 2008, Annals of Surgical Oncology.

[19]  W. Ajiki,et al.  Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001. , 2008, Japanese journal of clinical oncology.

[20]  Y. Fujii,et al.  Thoracic and cardiovascular surgery in Japan during 2006 , 2008, General thoracic and cardiovascular surgery.

[21]  K. Garsed,et al.  Narrow-band imaging with magnification in Barrett’s esophagus: validation of a simplified grading system of mucosal morphology patterns against histology , 2008, Endoscopy.

[22]  M. Stolte,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[23]  Fernando Ramos,et al.  A Randomized Comparison of Methylene Blue-Directed Biopsy Versus Conventional Four-Quadrant Biopsy for the Detection of Intestinal Metaplasia and Dysplasia in Patients With Long-Segment Barrett's Esophagus , 2008, The American Journal of Gastroenterology.

[24]  K. Abrams,et al.  Meta analysis: cancer risk in Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.

[25]  J. Reitsma,et al.  Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus: Five-Year Survival of a Randomized Clinical Trial , 2007, Annals of surgery.

[26]  B. Shadbolt,et al.  Effect of proton pump inhibitors on markers of risk for high‐grade dysplasia and oesophageal cancer in Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.

[27]  Kenneth K Wang,et al.  Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system , 2007, Gut.

[28]  J. Jankowski,et al.  Molecular changes in the progression of Barrett’s oesophagus , 2007, Postgraduate Medical Journal.

[29]  N. Soehendra,et al.  Endoscopic mucosal resection of Barrett’s oesophagus containing dysplasia or intramucosal cancer , 2007, Postgraduate Medical Journal.

[30]  J. Brill,et al.  Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  J. Hunter,et al.  Office-Based Unsedated Small-Caliber Endoscopy Is Equivalent to Conventional Sedated Endoscopy in Screening and Surveillance for Barrett's Esophagus: A Randomized and Blinded Comparison , 2006, The American Journal of Gastroenterology.

[32]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[33]  Teruhisa Kazui,et al.  Thoracic and cardiovascular surgery in Japan during 2004. , 2006, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[34]  R. Odze,et al.  AMACR Immunostaining is Useful in Detecting Dysplastic Epithelium in Barrett's Esophagus, Ulcerative Colitis, and Crohn's Disease , 2006, The American journal of surgical pathology.

[35]  J. Bergman,et al.  Autofluorescence Imaging and Narrow-Band Imaging for the Detection of Early Neoplasia in Patients with Barrett’s Esophagus , 2006, Endoscopy.

[36]  N. Ishimura,et al.  Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[37]  D. Corley,et al.  Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[38]  L. Lovat,et al.  Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance , 2006, Clinical Cancer Research.

[39]  D. Faigel,et al.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.

[40]  R. Playford.  New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus , 2006, Gut.

[41]  C. Gutschow,et al.  High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. , 2006, Endoscopy.

[42]  H. Fujita,et al.  Thoracic and cardiovascular surgery in Japan during 2003: annual report by The Japanese Association for Thoracic Surgery. , 2005, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[43]  Y. Hoshihara,et al.  [Endoscopic diagnosis of Barrett's esophagus]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[44]  J. Reynolds,et al.  Proinflammatory Cytokine and Nuclear Factor Kappa-B Expression along the Inflammation–Metaplasia–Dysplasia–Adenocarcinoma Sequence in the Esophagus , 2005, The American Journal of Gastroenterology.

[45]  K. Mafune,et al.  Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett's esophagus? , 2005, Human pathology.

[46]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[47]  M. Wallace,et al.  Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.

[48]  A. Bhattacharyya,et al.  Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.

[49]  J. Reynolds,et al.  Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. , 2004, American journal of surgery.

[50]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[51]  K. Sugano,et al.  Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice , 2003, Gut.

[52]  A. Bhattacharyya,et al.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus , 2003, Gut.

[53]  K. Yasuda,et al.  Thoracic and Cardiovascular Surgery in Japan during 2000 : Annual Report by The Japanese Association for Thoracic Surgery , 2002 .

[54]  N. Altorki,et al.  Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus , 2002, Annals of surgery.

[55]  K. Sugano,et al.  Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. , 2002, Biochemical and biophysical research communications.

[56]  S. Spechler,et al.  Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.

[57]  F. Bosman,et al.  Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. , 2002, American journal of clinical pathology.

[58]  A. Sonnenberg,et al.  Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma. , 2001, Gastroenterology.

[59]  D. Provenzale,et al.  Clinical and Demographic Predictors of Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease: A Multivariable Analysis in Veterans , 2001, Journal of clinical gastroenterology.

[60]  J. Peters,et al.  Long-Term Outcome of Antireflux Surgery in Patients With Barrett’s Esophagus , 2001, Annals of surgery.

[61]  S. Attwood,et al.  Cyclooxygenase-2 expression in the Barrett’s metaplasia–dysplasia–adenocarcinoma sequence , 2001 .

[62]  J. Devière,et al.  Argon Plasma Coagulation in the Treatment of Barrett’s High-Grade Dysplasia and In Situ Adenocarcinoma , 2001, Endoscopy.

[63]  G. Falk,et al.  Practice patterns for surveillance of Barrett's esophagus in the united states. , 2000, Gastrointestinal endoscopy.

[64]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[65]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[66]  N. Powe,et al.  Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[67]  M. Guelrud,et al.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[68]  R. Cherian,et al.  Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD, barrett's esophagus, barrett's dysplasia, and barrett's adenocarcinoma , 2000, American Journal of Gastroenterology.

[69]  N. Powe,et al.  Management of Barrett's esophagus: a national study of practice patterns and their cost implications , 1999, American Journal of Gastroenterology.

[70]  L. Bonavina,et al.  Current trends in the surgical treatment of esophageal and cardia adenocarcinoma. , 1999, Journal of experimental & clinical cancer research : CR.

[71]  P. D. De Leyn,et al.  Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[72]  J. Cooper,et al.  Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01) , 1999 .

[73]  H. Yasui,et al.  Thoracic and cardiovascular surgery in Japan during 1997. Annual report by the Japanese Association for Thoracic Surgery. Committee of Science. , 1999, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[74]  D. Coppola,et al.  Significance of Fas and Retinoblastoma Protein Expression During the Progression of Barrett’s Metaplasia to Adenocarcinoma , 1999, Annals of Surgical Oncology.

[75]  A. Bhattacharyya,et al.  Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. , 1999, Gastrointestinal endoscopy.

[76]  E. Kuipers,et al.  Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. , 1999 .

[77]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[78]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[79]  K. Washington,et al.  Expression of β-catenin, α-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas , 1998 .

[80]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[81]  T. Hattori,et al.  Reflux of duodenal or gastro‐duodenal contents induces esophageal carcinoma in rats , 1996, International journal of cancer.

[82]  T. Lerut,et al.  Surgical treatment of Barrett's carcinoma , 1994 .

[83]  R. Lebovitz,et al.  p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.

[84]  W. Meyer,et al.  Barrett-esophagus Following Total Gastrectomy*: A Contribution to it's Pathogenesis , 1979, Endoscopy.

[85]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[86]  P. Allison,et al.  The Oesophagus Lined with Gastric Mucous Membrane , 1953, Thorax.

[87]  N. Barrett.  Chronic peptic ulcerz of the œophagus and ‘œsophagitis’ , 1950 .

[88]  E. Ikeda,et al.  REPORT OF A CASE , 2007 .

[89]  C. Mariette,et al.  Esophageal Carcinoma: Prognostic Differences between Squamous Cell Carcinoma And Adenocarcinoma , 2004, World Journal of Surgery.

[90]  K. Kerlikowske,et al.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.

[91]  ten,et al.  UvA-DARE (Digital Academic Repository) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma the esophagus , 2002 .

[92]  日本食道疾患研究会.  Comprehensive registry of esophageal cancer in Japan (1995, 1996, 1997) , 2001 .

[93]  R. Ward,et al.  Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. , 2000, The Australian and New Zealand journal of surgery.

[94]  S. Law.  Chemoradiotherapy - panacea for esophageal cancer? Commentary for 'Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)' , 1999 .

[95]  K. Washington,et al.  Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[96]  K. Takubo,et al.  Ducts Of Esophageal Glands Proper And Paneth Cells In Barrett'S Esophagus: Frequency in biopsy specimens , 1995, Pathology.

[97]  N R BARRETT,et al.  The lower esophagus lined by columnar epithelium. , 1957, Surgery.

[98]  N R BARRETT,et al.  Chronic peptic ulcer of the oesophagus and 'oesophagitis'. , 1950, The British journal of surgery.